The Food and Drug Administration (FDA) has granted approval for Eli Lilly’s drug tirzepatide, marking a significant development in the obesity treatment landscape in the United States. The active ingredient in tirzepatide has already received approval for the treatment of Type 2 diabetes as Mounjaro since May 2022. The new FDA approval enables adults with… Continue reading FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drug

A new health tech startup called Cercle launched Wednesday and announced major global partners and investors, including Meta’s former COO Sheryl Sandberg. Cercle uses artificial intelligence to try and advance women’s health, particularly within fertility care. The company’s platform organizes unstructured medical data, such as medical records and test results, into a standardized format for fertility doctors and researchers,… Continue reading Health AI startup Cercle debuts with backing from Sheryl Sandberg

Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (“Justera” or the “Company“) is pleased to announce that the Company’s wholly-owned subsidiary, Juillet Wellness Centre, (“Juillet Wellness“), has launched an extended range of premium laser treatment services with CUTERA XEO (“XEO“). XEO is manufactured by one of the industry leaders, Cutera Face and Body Aesthetic Solutions… Continue reading Justera Health Launches Premium Laser Treatment with CUTERA XEO

French prosecutors have initiated a preliminary investigation into pharmaceutical company Sanofi over potential market manipulation. The Parquet National Financier, the French financial prosecutor, began the probe in March 2023, focusing on alleged “dissemination of false or misleading information and price manipulation” in connection with Sanofi’s past financial communications. Sanofi, in response, has stated that it… Continue reading French prosecutors investigating Sanofi over possible market manipulation

Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (“Justera” or the “Company“) is pleased to announce it has taken a significant step towards expanding its portfolio by signing a definitive agreement to acquire all of the shares of Triniti Trading Corp. an authorized distributor of TonyMoly in Canada (o/a TonyMoly Canada (the “Vendor“)), a highly… Continue reading Justera Health (CSE:VTAL) Signs Definitive Agreement to Acquire K-Beauty Company, Triniti Trading Corp.

Novo Nordisk has reported that 80% of U.S. patients with insurance coverage who use its weight loss treatment Wegovy are paying less than $25 per month for the drug, despite its list price of around $1,350. This suggests that many insured Americans have access to the drug without bearing the full cost. While some U.S.… Continue reading Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month

E-cigarette usage among high school students in the United States has decreased, according to the 2023 National Youth Tobacco Survey. The survey revealed that between 2022 and 2023, e-cigarette use among high school students dropped from 14.1% to 10%, which translates to approximately 580,000 fewer high schoolers using e-cigarettes. Overall tobacco smoking among this age… Continue reading High school kids are vaping less, FDA and CDC say

The article discusses Moderna’s third-quarter performance, its plans to scale back Covid vaccine production, and its future outlook. Here are the key points: Moderna’s financial performance in Q3 showed the impact of changes related to the Covid vaccine business, and the company is now positioning itself to diversify and expand its vaccine offerings beyond the… Continue reading Moderna stock falls as sinking Covid vaccine demand drives steep loss

Eli Lilly reported its third-quarter results, showcasing robust demand for its diabetes drug, Mounjaro, which contributed to strong revenue and adjusted earnings. Here’s a breakdown of Eli Lilly’s third-quarter performance compared to Wall Street expectations: In the third quarter, Eli Lilly experienced a loss of $57.4 million, equivalent to 6 cents per share, compared to… Continue reading Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook

The article you provided discusses the new American Cancer Society guidelines for lung cancer screening. These guidelines expand eligibility for regular scans to detect lung cancer early. The previous recommendations focused on people aged 50 to 80 who had smoked at least 20 “pack years” and were either current smokers or had quit within the… Continue reading New lung cancer screening guidelines expand who should get tested annually

CVS reported its third-quarter earnings, with results surpassing Wall Street expectations. The company recorded sales of $89.76 billion, an increase of nearly 11% compared to the same period last year. Despite these positive figures, CVS shares dipped about 5% due to higher-than-expected medical costs in its insurance unit. The company’s adjusted earnings per share of… Continue reading CVS results top expectations, lifted by strong health services revenue

Doximity, a medical website used by over 80% of U.S. doctors, has launched a free service called DocDefender to help protect physicians’ personal information from online harassment. This initiative comes in response to increased levels of harassment and violence experienced by healthcare workers during the COVID-19 pandemic, which has been exacerbated by the politicization of… Continue reading Doctors have a new way to scrub personal information from internet after spike in harassment